Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database

Nicolas H. Thurin,Magali Rouyer,Marine Gross-Goupil,Xavier Rebillard,Michel Soulié,Thibaud Haaser,Mathieu Roumiguié,Sylvestre Le Moulec,Camille Capone,Marie Pierrès,Stéphanie Lamarque,Jérémy Jové,Emmanuelle Bignon,Cécile Droz-Perroteau,Nicholas Moore,Patrick Blin

Cancer Epidemiology（2020）

Cited 13|Views62

No score

Abstract

•First estimates of mCRPC incidence and prevalence.•Based on a validated algorithm and the French nationwide healthcare database.•Estimates standardized on the European Standard Population.•Annual incidence of mCRPC: 21 per 100 000 men.•Prevalence of mCRPC: 62 per 100 000 men.

Translated text

Key words

Administrative claims,Healthcare,Database,Epidemiology,Incidence,Prevalence,Prostate cancer,Prostatic neoplasms,Castration-resistant,Neoplasm metastasis,Pharmacoepidemiology,Validation study

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined